Le Lézard
Classified in: Health
Subjects: HEALTH, GOVERNMENT CONTRACTS

CCSA and Health Canada Invest $1.8 Million in Cannabis Research Projects


OTTAWA, Jan. 21, 2021 (GLOBE NEWSWIRE) -- It has been more than two years since Canada became the first G20 country to legalize recreational cannabis and cannabis products. The Canadian Centre on Substance Use and Addiction (CCSA) is investing $1.8 million dollars in research on non-therapeutic cannabis and the impacts of its legalization on public health and safety throughout the country. Through financial support from Health Canada, CCSA is funding 19 projects on subjects ranging from cannabis legalization and mental health to a comparison of legal versus illicit cannabis sales.

All levels of government need evidence and information to inform cannabis policy and regulation. The projects chosen for this CCSA initiative also include research on specific populations such as Indigenous peoples, veterans, and pregnant and breastfeeding mothers.

Each project will receive funding of up to $100,000 over two years. The Mental Health Commission of Canada is contributing $100,000 to support awarded projects with a mental health focus for a combined research investment of $1.8 million.

"These projects are an opportunity to significantly increase our understanding of cannabis in Canada today. They explore so many different topics: from product labelling regulations to the risks and potential benefits of CBD and THC to cannabis' effect on mental health. The evidence generated from this research will inform and help evaluate the impacts cannabis regulation has had since the Cannabis Act was passed in 2018," explained Rita Notarandrea, CEO of CCSA.

Following a call for proposals last year to explore areas in cannabis policy and research, CCSA awarded funding to the successful applicants through an independent review panel and rigorous peer-reviewed scoring process.

As part of this initiative, CCSA created the Canadian Cannabis Research Database, an online tool capturing current and ongoing cannabis research activities in Canada. CCSA has also created an interactive policy map to support researchers and the public with up-to-date information on the different provincial and territorial regulations and bylaws.

Please see the list of successful proposals and project summaries.

Media contact

Wendy Schlachta, Communications Advisor, Canadian Centre on Substance Use and Addiction
Tel.: 1-833-235-4048, extension 285  I  Email: [email protected]  I  Twitter: @CCSAcanada

CCSA was created by Parliament to provide national leadership to address substance use in Canada. A trusted counsel, we provide national guidance to decision makers by harnessing the power of research, curating knowledge and bringing together diverse perspectives.

CCSA activities and products are made possible through a financial contribution from Health Canada. The views of CCSA do not necessarily represent the views of the Government of Canada.


These press releases may also interest you

at 04:04
As pet parents gear up for summertime adventures with their pets, NaturVet, the 30-year pioneer and present-day innovator of the pet health and wellness industry, offers supportive solutions with the Quiet Moments® Calming Aids. The extensive...

at 04:01
Allied Market Research published a report, titled, "Ventricular Assist Devices Market By Product (Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), and Biventricular Assist Devices (BIVADs)), Application...

at 04:00
Slone Partners, a nationwide executive search firm for life sciences and healthcare organizations, has announced the placement of Dr. Eugene P. Kennedy, M.D, F.A.C.S. as Chief Medical Officer at Carisma Therapeutics Inc. ("Carisma"), a clinical-stage...

at 04:00
Chiesi Group, a research-oriented international biopharmaceutical group, proudly announces the signing of a memorandum of...

at 03:30
Alchemab Therapeutics (Alchemab), an antibody discovery company identifying naturally occurring antibodies from individuals resilient to disease, today announces the publication of a peer reviewed article titled "Predictability of B cell clonal...

at 03:00
Viewpoint, a national educational program hosted by renowned actor Dennis Quaid, will be shooting an episode with Maine-based behavioral health organization, Sweetser. The upcoming episode, scheduled to film on May 30th, will focus on addressing the...



News published on and distributed by: